The committees will focus on clinical evaluation. It will include using and developing disease specific quality of life measures, radiologic evaluation of POP and identifying co-disease such as urinary incontinence, fecal incontinence, sexual dysfunction and pelvic pain.

Committees

  1. Quality of life questionnaires

    This committee will evaluate those health related quality of life (HRQoL) questionnaires that have been developed specifically for patients with pelvic organ prolapse. This will include evaluating the validity and reliability of this family of HRQoL questionnaires with an aim toward recommending which tools have clinical versus research value and the strength behind these recommendations. This committee with also evaluate which HRQol questionnaires have been translated into other languages and the rigor of this translation process to make recommendations on which tools can be reliably used in which languages.  Final recommendations on how to use these tools in; 1). clinical practice to aid clinicians with identify those patients with clinically significant pelvic organ prolapse and 2). research applications for both epidemiology studies and therapeutic trials.

    Steering Committee Advisor
    Maria Bortolini (Brazil)

    Committee Chair
    Rebecca Rogers (USA)             

    Committee Members
    Mageed Abdelrahman (United Kingdom)
    Ahmed Al-Badr (Saudi Arabia)
    Sara Cichowski (USA)

    Montserrat Espuña (Spain)
    Magdalena Grzybowska (Poland)
    Gabriela Halder (USA)
    Sierra Jansen (USA)
    Swati Jha (United Kingdom)

    Daniela Ulrich (Austria)

  1. Radiologic evaluation

    This committee will evaluate the literature on the use of radiologic investigation into the clinical investigation of pelvic organ prolapse. This will include evaluating how radiographic studies can aid in the diagnostic evaluation of pelvic organ prolapse and in understanding mechanisms of disease and prognosis. The committee with confine search and recommendations to the body of literature evaluating pelvic organ prolapse and will not evaluate those radiographic studies evaluating co-morbid conditions (ie urinary retention and hydronephrosis, evacuation disorders, or fecal or urinary incontinence). The overall aim of this committee will be to make recommendations as to which radiographic studies can aid the clinician in the clinical evaluation of the patient with pelvic organ prolapse and which radiographic investigations remain in the realm of research related activities. 

    Steering Committee Advisor
    Lynsey Hayward (New Zealand)

    Committee Chair
    Lieschen Quiroz (USA)   

    Committee Members
    Megan Bradley (USA)
    Rachel Cheung (Hong Kong)
    Ankita Sundeep Gupta (USA)
    Sharif Ismail (United Kingdom)
    Roopali Karmarkar (United Kingdom)
    Vikram (Vik) Khullar (United Kingdom)
    Lioudmila Lipetskaia (USA)
    Ghazaleh Rostaminia (USA)
  1. Clinical evaluation to include investigations into associated Morbidity/Pelvic floor dysfunction (Potential incontinence, urinary retention/voiding dysfunction, sexual dysfunction, pelvic pain and GI abnormalities)

    This committee will evaluate the literature on the clinical evaluation of the patients with pelvic organ prolapse. This will include how to use the physical exam to describe pelvic organ support or prolapse, associated testing to evaluate for comorbid conditions. Evaluation of the methods currently available to assess for comorbid urinary tract and gastrointestinal tract dysfunction will be covered by this committee. The aim of this committee will be to establish the physical exam components and associated testing which make up the basic evaluation of the patient with isolated complaints of pelvic organ prolapse. This committee with not cover the primary evaluation of associated complaints, such as urinary incontinence or fecal incontinence, in subjects with pelvic organ prolapse unless these evaluations are different and unique in subjects with co-existing pelvic organ prolapse.

    Steering Committee Advisor
    Bob Freeman (United Kingdom)

    Committee Chair
    Anna Rosamilia (Australia)   

    Committee Members   
    Heather Barbier (USA)
    Cassandra Carberry (USA)
    Paivi Karjalainen (Finland)
    Charlotte Mahoney (United Kingdom)
    Valentín Manríquez Galán (Chile)
    Esther Ruess (South Africa)
    David Shaker (Australia)
    Karishma Thariani (India)

Timeline

The duration of the commitment is 3 years. The committees are have begun working together. Each committee has been invited to meet in person at the IUGA Annual Meeting June 24-27, 2020 in The Hague, The Netherlands. A private meeting room will be provided for 2 hours to finalize the scope of the report. After the scope of the report is finalized, each committee will present their ideas to the attendees of the IUGA Annual Meeting at a dedicated consultation session. The IUC session will take place on Friday, June 26 from 8:00am-10:00am. Each committee will have 10 minutes to present their ideas followed by 5 minutes of questions and discussion with the audience.

After the consultation session at the IUGA Annual Meeting in 2020, the committee will have 12 months to finalize their recommendations and write the manuscript. This final work may be presented by the committee at the IUGA Annual Meeting in Singapore in 2021. Immediately following the Annual Meeting, the final manuscript will be submitted to the IUJ in 2021 with the aim to be published in the beginning of 2022.

Expectations

  • The manuscripts will be developed using a collaborative process that requires regular communication email, periodic conference calls, and completion of assignments. Although many communications will be by email, Committee Chairs and Members are required to participate in teleconferences and in-person meetings.
  • Committee Members will thoroughly research their topic or sub-topic, as specified by chair.
  • Committee Members commit to produce and deliver all completed assignments and required information before the specified and agreed upon deadlines.
  • Committee Chairs and Members will disclose all potential Conflicts of Interest. To see the IUGA Conflict of Interest policy, please click here.

The committee, Committee Chair, and Committee Members are expected to meet all deadlines unless there are extenuating circumstances. In those cases, the Committee Chair is required to notify of their Steering Committee Member, Steering Committee Chairs and the IUGA Office before the missed deadline or as soon as is possible following the deadline. Any Committee Chair or Committee Member that does not meet these requirements, is unresponsive to more than 4 consecutive emails, or does not remain in regular contact with the Steering Committee and IUGA Office will be promptly replaced.

Experience

  • Committee Members must have completed training at the Masters, MD, and/or or PhD level
  • Committee Members must be an expert in the topic of their respective committee.